GAITHERSBURG, Md., April 7, 2014 (GLOBE NEWSWIRE) -- Cytomedix, Inc. (OTCQX:CMXI), a leading developer of biologically active regenerative therapies, announced today the appointment of Andrew Cohen as Vice President of Marketing. He will have overall marketing responsibilities as the Company moves forward with its commercial plan to launch AutoloGelTM in the wound care market. He will report to Dean Tozer, Executive Vice President and Chief Commercial Officer.
Help employers find you! Check out all the jobs and post your resume.
